Want to join the conversation?
$REGN and $SNY said SARIL-RA-MONARCH Phase 3 monotherapy study met its primary endpoint, showing that sarilumab was superior to adalimumab in improving symptoms in patients with active rheumatoid arthritis at week 24. Study also met secondary endpoints like other measures gauging improvements in signs and symptoms of RA and physical function.
$PYPL jumps 6% in after hours on strong results. I am bullish on this stock.
$TSCO stock remained active in the after hours trading and rose more than 2% after the retailer posted better than expected 1Q17 results.
Instagram has reached 700 million monthly active users. Looks like it will hit 1 billion soon. That would make it $FB’s fourth billion-user platform.